Regulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment

Journal of Neuroscience

Volumn 33, Issue 43, 2013, Pages 16930-16944

  Hoeffer, Charles A ^a,b   Wong, Helen ^a,b   Cain, Peter ^c   Levenga, Josien ^a   Cowansage, Kiriana K ^b   Choi, Yoon ^a   Davy, Camille ^a   Majmundar, Neil ^b   Randy McMillan, D ^d   Rothermel, Beverly A ^d   Klann, Eric ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c EXCELSIOR COLLEGE   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLUOXETINE; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DNA SYNTHESIS; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENOTYPE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; WESTERN BLOTTING;

ANIMALS; ANXIETY; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCINEURIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FLUOXETINE; GENE DELETION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUSCLE PROTEINS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; REACTION TIME; SEROTONIN UPTAKE INHIBITORS;

EID: 84886936981     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3513-12.2013     Document Type: Article

References (76)

1. Alberts A.S., Montminy M, Shenolikar S, Feramisco JR (1994) Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Biol 14:4398-4407. Medline
2. Bahi A., Mineur YS, Picciotto MR (2009) Blockade of protein phosphatase 2B activity in the amygdala increases anxiety-and depression-like behaviors in mice. Biol Psychiatry 66:1139-1146. CrossRef Medline
3. Baldwin D.S., TiwariN (2009) The pharmacologic treatment of patients with generalized anxiety disorder: where are we now and where are we going? CNS Spectr 14:5-12. Medline
4. Barrot M., Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm D.R., Neve RL, Yin JC, Zachariou V, Nestler EJ (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A 99:11435-11440. CrossRef Medline
5. Baumgärtel K., Mansuy IM (2012) Neural functions of calcineurin in synaptic plasticity and memory. Learn Mem 19:375-384. CrossRef Medline
6. Belzung C., Le Guisquet AM, Barreau S, Calatayud F (2001) An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice. Behav Pharmacol 12:151-162. CrossRef Medline
7. Bito H., Deisseroth K, Tsien RW (1996) CREB phosphorylation and dephosphorylation: a Ca(2+)-and stimulus duration-dependent switch for hippocampal gene expression. Cell 87:1203-1214. CrossRef Medline
8. Bouwknecht J.A., Paylor R (2008) Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav Pharmacol 19:385-402. CrossRef Medline
9. Carlezon W.A. Jr, Duman RS, Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28:436-445. CrossRef Medline
10. Carme Mulero M, OrzáezM, Messeguer J, Messeguer A, Pérez-Payá E, Pérez- RibaM (2010) A fluorescent polarization-based assay for the identification of disruptors of the RCAN1-calcineurin A protein complex. Anal Biochem 398:99-103. CrossRef Medline
11. Carobrez A.P., Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193-1205. CrossRef Medline
12. Chan B., Greenan G, McKeon F, Ellenberger T (2005) Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci U S A 102:13075-13080. CrossRef Medline
13. Chang K.T., Berg DK (2001) Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron 32:855-865. CrossRef Medline
14. Chen Z.Y., Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C., McEwen BS, Hempstead BL, Lee FS (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140-143. CrossRef Medline
15. Ch'ng TH, Uzgil B, Lin P, Avliyakulov NK, O'Dell TJ, Martin KC (2012) Activity-dependent transport of the transcriptional coactivator CRTC1 from synapse to nucleus. Cell 150:207-221. CrossRef Medline
16. Crozatier C., Farley S, Mansuy IM, Dumas S, Giros B, Tzavara ET (2007) Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants. Neuroscience 144:1470-1476. CrossRef Medline
17. Deacon R.M., Penny C, Rawlins JN (2003) Effects of medial prefrontal cortex cytotoxic lesions in mice. Behav Brain Res 139:139-155. CrossRef Medline
18. Den Boer JA, Westenberg HG (1990) Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 102:85-94. CrossRef Medline
19. Duman C.H., Duman RS (2005) Neurobiology and treatment of anxiety: signal transduction and neural plasticity. Handb Exp Pharmacol 305-334. Medline
20. Elwood L.S., Wolitzky-Taylor K, Olatunji BO (2012) Measurement of anxious traits: a contemporary review and synthesis. Anxiety Stress Coping 25:647-666. CrossRef Medline
21. Endler N.S., Kocovski NL (2001) State and trait anxiety revisited. J Anxiety Disord 15:231-245. CrossRef Medline
22. Fayard B., Loeffler S, Weis J, Vögelin E, Krüttgen A (2005) The secreted brain-derived neurotrophic factor precursor pro-BDNF binds to TrkB and p75NTR but not to TrkA or TrkC. J Neurosci Res 80:18-28. CrossRef Medline
23. File S.E., Mabbutt PS, Hitchcott PK (1990) Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berl) 102:98-101. CrossRef Medline
24. Finkbeiner S., Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME (1997) CREB: a major mediator of neuronal neurotrophin responses. Neuron 19:1031-1047. CrossRef Medline
25. Forss-Petter S, Danielson PE, Catsicas S, Battenberg E, Price J, Nerenberg M, Sutcliffe J.G. (1990) Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 5:187-197. CrossRef Medline
26. Frielingsdorf H., Bath KG, Soliman F, Difede J, Casey BJ, Lee FS (2010) Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. Ann N Y Acad Sci 1208:150-157. CrossRef Medline
27. Garcia R., Vouimba RM, Baudry M, Thompson RF (1999) The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 402:294-296. CrossRef Medline
28. Genoux D., Haditsch U, Knobloch M, Michalon A, Storm D, Mansuy IM (2002) Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418:970-975. CrossRef Medline
29. Gerber D.J., Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S (2003) Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineu-rin gamma subunit. Proc Natl Acad Sci U S A 100:8993-8998. CrossRef Medline
30. Gerges N.Z., Aleisa AM, Schwarz LA, Alkadhi KA (2003) Chronic psychosocial stress decreases calcineurin in the dentate gyrus: a possible mechanism for preservation of early ltp. Neuroscience 117:869-874. CrossRef Medline
31. Gould T.D., ed (2009) Mood and anxiety related phenotypes in mice. Characterizing using behavioral tests. Saskatoon, SK, Canada: Humana.
32. Grillon C., Levenson J, Pine DS (2007) A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 32:225-231. CrossRef Medline
33. Hilioti Z., Gallagher DA, Low-Nam ST, Ramaswamy P, Gajer P, Kingsbury TJ, Birchwood C.J., Levchenko A, Cunningham KW (2004) GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev 18:35-47. CrossRef Medline
34. Hoeffer C.A., Dey A, Sachan N, Wong H, Patterson RJ, Shelton JM, Richardson JA, Klann E, Rothermel BA (2007) The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J Neurosci 27:13161-13172. CrossRef Medline
35. Hoeffer C.A., Tang W, Wong H, Santillan A, Patterson RJ, Martinez LA, Tejada-Simon MV, Paylor R, Hamilton SL, Klann E (2008) Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 60:832-845. CrossRef Medline
36. Hongpaisan J., Winters CA, Andrews SB (2003) Calcium-dependent mitochondrial superoxide modulates nuclear CREB phosphorylation in hippocampal neurons. Mol Cell Neurosci 24:1103-1115. CrossRef Medline
37. Jiang X, XuK, HobermanJ, Tian F, MarkoAJ, WaheedJF, HarrisCR, MariniAM, EnochMA, LipskyRH (2005) BDNFvariation andmooddisorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30:1353-1361. Medline
38. Jick H., Kaye JA, Jick SS (2004) Antidepressants and the risk of suicidal behaviors. JAMA 292:338-343. CrossRef Medline
39. Kingsbury T.J., Cunningham KW (2000) A conserved family of calcineurin regulators. Genes Dev 14:1595-1604. Medline
40. Kingsbury T.J., Bambrick LL, Roby CD, Krueger BK (2007) Calcineurin activity is required for depolarization-induced, CREB-dependent gene transcription in cortical neurons. J Neurochem 103:761-770. CrossRef Medline
41. Lam B.Y., Zhang W, Enticknap N, Haggis E, Cader MZ, Chawla S (2009) Inverse regulation of plasticity-related immediate early genes by calcineurin in hippocampal neurons. J Biol Chem 284:12562-12571. CrossRef Medline
42. Liotti M., Mayberg HS, Brannan SK, McGinnis S, Jerabek P, Fox PT (2000) Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry 48:30-42. CrossRef Medline
43. Liu F.C., Graybiel AM (1996) Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron 17:1133-1144. CrossRef Medline
44. Liu J., Garza JC, Bronner J, Kim CS, Zhang W, Lu XY (2010) Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine. Psychopharmacology (Berl) 207:535-545. CrossRef
45. Liu Q., Busby JC, Molkentin JD (2009) Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol 11:154-161. CrossRef Medline
46. Ludewig S., Ludewig K, Geyer MA, Hell D, Vollenweider FX (2002) Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety 15:55-60. CrossRef Medline
47. Manji H.K., Gottesman II, Gould TD (2003) Signal transduction and genesto-behaviors pathways in psychiatric diseases. Science's STKE: signal transduction knowledge environment 2003:pe49. Medline
48. Mantamadiotis T., Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A., Tronche F, Kellendonk C, Gau D, Kapfhammer J, Otto C, Schmid W., Schütz G (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31:47-54. CrossRef Medline
49. Martínez-Martínez S, Genescà L, Rodríguez A, Raya A, Salichs E, Were F, López-Maderuelo MD, Redondo JM, de la Luna S (2009) The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. Proc Natl Acad Sci U S A 106:6117-6122. CrossRef Medline
50. Martinowich K., Hattori D, WuH, Fouse S, He F, HuY, Fan G, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890-893. CrossRef Medline
51. Miyakawa T., Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron M.G., Tonegawa S (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A 100:8987-8992. CrossRef Medline
52. Molendijk M.L., van Tol MJ, Penninx BW, van der Wee NJ, Aleman A, Veltman DJ, Spinhoven P, Elzinga BM (2012) BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activity. Transl Psychiatry 2:e74. CrossRef Medline
53. Myers B.A., Pueschel SM (1991) Psychiatric disorders in persons with Down syndrome. J Nerv Ment Dis 179:609-613. CrossRef Medline
54. Myers-Schulz B, Koenigs M (2012) Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry 17:132-141. CrossRef Medline
55. Oh M., Rybkin II, Copeland V, Czubryt MP, Shelton JM, van Rooij E, Richardson JA, Hill JA, De Windt LJ, Bassel-Duby R, Olson EN, Rothermel BA (2005) Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. Mol Cell Biol 25:6629-6638. CrossRef Medline
56. Olfson M., Marcus SC, Shaffer D (2006) Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch Gen Psychiatry 63:865-872. CrossRef Medline
57. Pallanti S., Cantisani A, Grassi G (2013) Anxiety as a core aspect of schizophrenia. Curr Psychiatry Rep 15:354. CrossRef Medline
58. Pandey S.C., Zhang D, Mittal N, Nayyar D (1999) Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety. J Pharmacol Exp Ther 288:866-878. Medline
59. Rakofsky J.J., Ressler KJ, Dunlop BW (2012) BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol Psychiatry 17:22-35. CrossRef Medline
60. Rios M., Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15: 1748-1757. CrossRef Medline
61. Rothermel B.A., Vega RB, Williams RS (2003) The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med 13:15-21. CrossRef Medline
62. Rothermel B., Vega RB, Yang J, WuH, Bassel-Duby R, Williams RS (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275: 8719-8725. CrossRef Medline
63. Rushlow W.J., Seah C, Sutton LP, Bjelica A, Rajakumar N (2009) Antipsychotics affect multiple calcium calmodulin dependent proteins. Neuroscience 161:877-886. CrossRef Medline
64. Sanna B., Brandt EB, Kaiser RA, Pfluger P, Witt SA, Kimball TR, van Rooij E, De Windt LJ, Rothenberg ME, Tschop MH, Benoit SC, Molkentin JD (2006) Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo. Proc Natl Acad Sci U S A 103:7327-7332. CrossRef Medline
65. Schumacher J., Kristensen AS, Wendland JR, Nöthen MM, Mors O, McMahon FJ (2011) The genetics of panic disorder. J Med Genet 48:361-368. CrossRef Medline
66. Serkova N., Hausen B, Berry GJ, Jacobsen W, Benet LZ, Morris RE, Christians U (2000) Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine. J Pharmacol Exp Ther 294:323-332. Medline
67. Serkova N., Jacobsen W, Niemann CU, Litt L, Benet LZ, Leibfritz D, Christians U (2001) Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol 133:875-885. CrossRef Medline
68. Svenningsson P., Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302: 1412-1415. CrossRef Medline
69. 2+ influx regulates BDNF transcription by a CREB family transcription factordependent mechanism. Neuron 20:709-726. CrossRef Medline
70. Tsien J.Z., Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel E.R., Tonegawa S (1996) Subregion-and cell type-restricted gene knockout in mouse brain. Cell 87:1317-1326. CrossRef Medline
71. Vega R.B., Yang J, Rothermel BA, Bassel-Duby R, Williams RS (2002) Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 277:30401-30407. CrossRef Medline
72. Vega R.B., Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, Bassel-Duby R., Williams RS, Olson EN (2003) Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci U S A 100:669-674. CrossRef Medline
73. Wallace D.L., Han MH, Graham DL, Green TA, Vialou V, Iñiguez SD, Cao JL, Kirk A, Chakravarty S, Kumar A, Krishnan V, Neve RL, Cooper DC, Bolaños C.A., Barrot M, McClung CA, Nestler EJ (2009) CREB regulation of nucleus accumbens excitability mediates social isolationinduced behavioral deficits. Nat Neurosci 12:200-209. CrossRef Medline
74. Wall P.M., Messier C (2000) Concurrent modulation of anxiety and memory. Behav Brain Res 109:229-241. CrossRef Medline
75. Wu L.J., Kim SS, Zhuo M (2008) Molecular targets of anxiety: from membrane to nucleus. Neurochem Res 33:1925-1932. CrossRef Medline
76. Yang X.W., Lu XH (2011) Molecular and cellular basis of obsessivecompulsive disorder-like behaviors: emerging view from mouse models. Curr Opin Neurol 24:114-118. CrossRef Medline